Physician profile
Robert E James
NPI 1558380683
$5,410.37
in general payments reported to CMS, 2019-2025
33 companies · $799 in 2025
The $799 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $701 · 2020: $268 · 2021: $549 · 2022: $647 · 2023: $1,461 · 2024: $985 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,244.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,726.00 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $589.93 | 2019-2025 | Myrbetriq, Padcev |
| Abbvie INC. | $399.35 | 2019-2025 | |
| Urovant Sciences INC | $386.41 | 2022 | |
| Boston Scientific Corporation | $280.25 | 2019-2025 | Ams 700, Axonics |
| Janssen Biotech, INC. | $195.29 | 2019-2024 | Erleada, Akeega, Balversa |
| Janssen Scientific Affairs, LLC | $145.94 | 2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $142.49 | 2021-2024 | Prolaris |
| Coloplast Corp | $141.52 | 2021 | |
| Caldera Medical, INC | $140.17 | 2021 | |
| Astellas Pharma Global Development | $131.55 | 2025 | Xtandi |
| Allergan, INC. | $127.46 | 2019-2021 | |
| 180 Medical, INC. | $100.95 | 2021-2023 | Cure Catheter, Cure Ultra Catheter |
| Merck Sharp & Dohme LLC | $100.18 | 2020-2024 | Keytruda, Lynparza |
| Ferring Pharmaceuticals INC. | $88.80 | 2025 | Adstiladrin |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $80.68 | 2021-2022 | |
| Olympus America INC. | $80.33 | 2020 | |
| Dornier Medtech America, INC | $64.43 | 2023 | Dornier Medtech |
| Endo Pharmaceuticals INC. | $62.62 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.44 | 2019-2023 | |
| Neotract INC. | $51.72 | 2019 | |
| Angiodynamics, INC. | $49.32 | 2023 | Nanoknife |
| Ambu INC. | $44.13 | 2020-2021 | |
| Pfizer INC. | $36.47 | 2023-2024 | |
| Dendreon Pharmaceuticals LLC | $32.34 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $29.40 | 2019 | |
| Dentsply Ih INC. | $24.90 | 2019 | |
| Profound Medical Corp. | $24.34 | 2022 | |
| Smith+Nephew, INC. | $20.53 | 2024 | Stravix |
| Karl Storz Endoscopy-America | $16.91 | 2024 | |
| Axonics, INC. | $15.15 | 2021 | |
| Hollister Incorporated | $14.75 | 2022 | |
| Laborie Medical Technologies Corp. | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.